• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规自身抗体血清学阴性的特发性慢性活动性肝炎患者的自身免疫特征。

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.

作者信息

Johnson P J, McFarlane I G, McFarlane B M, Williams R

机构信息

Liver Unit, King's College Hospital, Denmark Hill, London, UK.

出版信息

J Gastroenterol Hepatol. 1990 May-Jun;5(3):244-51. doi: 10.1111/j.1440-1746.1990.tb01624.x.

DOI:10.1111/j.1440-1746.1990.tb01624.x
PMID:2103405
Abstract

In patients with chronic active hepatitis (CAH), the absence of the conventional serum auto-antibodies (antinuclear, smooth muscle and liver-kidney microsomal) is often taken as evidence against an auto-immune aetiology and as indicative that the disease is unlikely to respond to immunosuppressive therapy. We report 12 British patients (11 female) who presented with histologically florid CAH (11 with cirrhosis or fibrosis and seven with ascites) but without significant titres of these antibodies or any other demonstrable aetiological feature (cryptogenic CAH), who have been followed up for a median of 5.25 years (range: 0.75-16 years). Ten had hypergammaglobulinaemia and/or specific elevations of serum IgG concentrations at presentation and five of 10 patients tested were found to have the HLA allotypes B8 and DR3. Remission was initially induced with prednisolone with or without azathioprine in all patients. Six patients subsequently relapsed on one or more occasions, either spontaneously while on maintenance therapy or during attempts to withdraw corticosteroids, and required increases or reintroduction of immunosuppressive therapy to regain disease control. Retrospective analysis of pretreatment samples from 11 of the patients revealed that all had been seropositive at presentation for auto-antibodies against the liver membrane lipoprotein preparation known as liver-specific membrane lipoprotein (LSP) and/or against the hepatic asialoglycoprotein receptor (ASGP-R), titres of which subsequently fluctuated in direct relation to response to treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在慢性活动性肝炎(CAH)患者中,传统血清自身抗体(抗核抗体、平滑肌抗体和肝肾微粒体抗体)的缺乏常被视为排除自身免疫病因的证据,表明该疾病不太可能对免疫抑制治疗有反应。我们报告了12例英国患者(11例女性),他们表现为组织学上明显的CAH(11例有肝硬化或纤维化,7例有腹水),但这些抗体滴度不高,也没有任何其他可证实的病因特征(隐源性CAH),随访时间中位数为5.25年(范围:0.75 - 16年)。10例患者在就诊时有高球蛋白血症和/或血清IgG浓度特异性升高,10例接受检测的患者中有5例具有HLA同种异型B8和DR3。所有患者最初均使用泼尼松龙联合或不联合硫唑嘌呤诱导缓解。6例患者随后复发一次或多次,要么在维持治疗期间自发复发,要么在试图停用皮质类固醇期间复发,需要增加或重新引入免疫抑制治疗以重新控制疾病。对11例患者治疗前样本的回顾性分析显示,所有患者在就诊时针对称为肝特异性膜脂蛋白(LSP)的肝膜脂蛋白制剂和/或针对肝去唾液酸糖蛋白受体(ASGP - R)的自身抗体均为血清阳性,其滴度随后与治疗反应直接相关波动。(摘要截断于250字)

相似文献

1
Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.常规自身抗体血清学阴性的特发性慢性活动性肝炎患者的自身免疫特征。
J Gastroenterol Hepatol. 1990 May-Jun;5(3):244-51. doi: 10.1111/j.1440-1746.1990.tb01624.x.
2
Antibodies to liver-specific lipoprotein in children with chronic liver disease due to "autoimmune" chronic active hepatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency.患有因“自身免疫性”慢性活动性肝炎、囊性纤维化和α1抗胰蛋白酶缺乏症所致慢性肝病的儿童体内针对肝脏特异性脂蛋白的抗体。
J Pediatr Gastroenterol Nutr. 1984 Nov;3(5):728-33. doi: 10.1097/00005176-198411000-00016.
3
A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein.一种用于检测与肝去唾液酸糖蛋白受体蛋白发生反应的循环抗体的放射免疫测定法。
J Immunol Methods. 1985 Mar 18;77(2):219-28. doi: 10.1016/0022-1759(85)90034-1.
4
Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎中对肝细胞抗原的自身反应性。
J Clin Lab Immunol. 1989 Nov;30(3):103-9.
5
Auto-immune (lupoid) hepatitis: an entity in the spectrum of chronic active liver disease.自身免疫性(狼疮样)肝炎:慢性活动性肝病谱中的一种疾病。
J Gastroenterol Hepatol. 1990 May-Jun;5(3):352-9. doi: 10.1111/j.1440-1746.1990.tb01637.x.
6
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.导致儿童原发性硬化性胆管炎和自身免疫性慢性活动性肝炎自身免疫的不同免疫机制。
Hepatology. 1989 Feb;9(2):198-203. doi: 10.1002/hep.1840090206.
7
Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.肝脏特异性蛋白抗体可预测自身免疫性慢性活动性肝炎治疗停药的预后。
Lancet. 1984 Oct 27;2(8409):954-6. doi: 10.1016/s0140-6736(84)91167-x.
8
Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis.自身免疫性慢性活动性肝炎中针对肝细胞膜特异性抗原、肝特异性脂蛋白和Tamm-Horsfall糖蛋白自身抗体的临床评估
Gastroenterol Jpn. 1987 Feb;22(1):24-33. doi: 10.1007/BF02806331.
9
Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.自身免疫性慢性活动性肝炎中浸润肝脏的辅助性T细胞可在体外刺激抗人去唾液酸糖蛋白受体自身抗体的产生。
Clin Exp Immunol. 1992 Apr;88(1):45-9. doi: 10.1111/j.1365-2249.1992.tb03037.x.
10
Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.
J Hepatol. 1986;3(2):196-205. doi: 10.1016/s0168-8278(86)80026-5.

引用本文的文献

1
Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome.青少年自身免疫性肝炎:诊断、管理及长期预后的最新进展
Diagnostics (Basel). 2023 Aug 24;13(17):2753. doi: 10.3390/diagnostics13172753.
2
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.自身免疫性肝炎的诊断与管理:现状与未来方向
Gut Liver. 2016 Mar;10(2):177-203. doi: 10.5009/gnl15352.
3
Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.去唾液酸糖蛋白受体(ASGPR):肝脏特异性自身免疫的独特靶点。
Auto Immun Highlights. 2012 Oct 30;3(3):119-25. doi: 10.1007/s13317-012-0041-4. eCollection 2012 Dec.
4
Autoantibody-negative autoimmune hepatitis.自身抗体阴性自身免疫性肝炎。
Dig Dis Sci. 2012 Mar;57(3):610-24. doi: 10.1007/s10620-011-2017-z. Epub 2011 Dec 21.
5
Cryptogenic chronic hepatitis and its changing guise in adults.成人不明原因慢性肝炎及其变化形式。
Dig Dis Sci. 2011 Dec;56(12):3421-38. doi: 10.1007/s10620-011-1769-9. Epub 2011 Jun 7.
6
Autoantibodies as prognostic markers in autoimmune liver disease.自身抗体作为自身免疫性肝病的预后标志物。
Dig Dis Sci. 2010 Aug;55(8):2144-61. doi: 10.1007/s10620-010-1268-4. Epub 2010 May 13.
7
Coeliac disease and liver dysfunction.乳糜泻与肝功能障碍。
Arch Dis Child. 2002 Oct;87(4):293-6. doi: 10.1136/adc.87.4.293.
8
Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.作为人类自身免疫性疾病自身抗原的外源性代谢酶。最新进展。
Clin Rev Allergy Immunol. 2000 Apr;18(2):215-39. doi: 10.1385/CRIAI:18:2:215.
9
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.自身免疫性肝炎中自身免疫标志物与不同临床综合征之间的关系。
Gut. 1998 May;42(5):599-602. doi: 10.1136/gut.42.5.599.
10
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.他克莫司:自身免疫性慢性活动性肝炎的一种潜在新疗法:一项开放标签初步试验的结果
Am J Gastroenterol. 1995 May;90(5):771-6.